Fruzaqla (fruquintinib) - Takeda
A Study of Fruquintinib in Adults With Metastatic Colorectal Cancer in Poland (clinicaltrials.gov) - Sep 23, 2026 - P=N/A | N=110 | Recruiting | Sponsor: Takeda | Not yet recruiting ➔ Recruiting 
Enrollment open • Real-world evidence • Colorectal Cancer • Oncology • Solid Tumor
http://clinicaltrials.gov/ct2/show/NCT07623174
 
Sep 23, 2026
 
Prev Next